A study on the relationship between HCV NS3 and endogenous IRF-3

A study on the relationship between HCV NS3 and endogenous IRF-3

This study aims to investigate the relationship between hepatitis C virus (HCV) NS3/4A and endogenous interferon regulatory factor-3 (IRF-3). The localization of endogenous IRF-3 protein before and after virus infection was analyzed by immunofluorescence assay (IFA). IFA results revealed that the sy...

Full description

Bibliographic Details
Main Authors:	Hong-Ping Liang, Hotta Hak, Jian-Min Ji
Format:	Article
Language:	English
Published:	SAGE Publishing 2018-07-01
Series:	European Journal of Inflammation
Online Access:	https://doi.org/10.1177/2058739218784453

Similar Items

Host APOBEC3G protein inhibits HCV replication through direct binding at NS3.
by: Yan-Ping Zhu, et al.
Published: (2015-01-01)

Synthetic bulky NS4A peptide variants bind to and inhibit HCV NS3 protease
by: Moustafa E. El-Araby, et al.
Published: (2020-07-01)

A conserved NS3 surface patch orchestrates NS2 protease stimulation, NS5A hyperphosphorylation and HCV genome replication.
by: Olaf Isken, et al.
Published: (2015-03-01)

A revisit into the Den2 NS2B/NS3 virus protease homology model: Structural verification and comparison with crystal structure of HCV NS3/4A and Den2 NS3
by: Lee, Y.K., et al.
Published: (2006)

HCV NS5A protein containing potential ligands for both Src homology 2 and 3 domains enhances autophosphorylation of Src family kinase Fyn in B cells.
by: Kenji Nakashima, et al.
Published: (2012-01-01)

VAPC, an human endogenous inhibitor for hepatitis C virus (HCV) infection, is intrinsically unstructured but forms a "fuzzy complex" with HCV NS5B.
by: Shaveta Goyal, et al.
Published: (2012-01-01)

Effects of Lower Temperature on Expression and Biochemical Characteristics of HCV NS3 Antigen Recombinant Protein
by: Chen-Ji Huang, et al.
Published: (2021-10-01)

Resistance Analyses of HCV NS3/4A Protease and NS5B Polymerase from Clinical Studies of Deleobuvir and Faldaprevir.
by: Kristi L Berger, et al.
Published: (2016-01-01)

Correction: A Conserved NS3 Surface Patch Orchestrates NS2 Protease Stimulation, NS5A Hyperphosphorylation and HCV Genome Replication.
by: Olaf Isken, et al.
Published: (2016-01-01)

Docking studies of Pakistani HCV NS3 helicase: a possible antiviral drug target.
by: Kaneez Fatima, et al.
Published: (2014-01-01)

Hepatitis C virus core, NS3, NS4B and NS5A are the major immunogenic proteins in humoral immunity in chronic HCV infection
by: Lappalainen Maija, et al.
Published: (2009-06-01)

Hesperidin identified from Citrus extracts potently inhibits HCV genotype 3a NS3 protease
by: Mahim Khan, et al.
Published: (2022-04-01)

Probing of exosites leads to novel inhibitor scaffolds of HCV NS3/4A proteinase.
by: Sergey A Shiryaev, et al.
Published: (2012-01-01)

Engineered toxins "zymoxins" are activated by the HCV NS3 protease by removal of an inhibitory protein domain.
by: Assaf Shapira, et al.
Published: (2011-01-01)

Identification of NS2 determinants stimulating intrinsic HCV NS2 protease activity.
by: Olaf Isken, et al.
Published: (2022-06-01)

Evaluation of the immunogenicity of liposome encapsulated HVR1 and NS3 regions of genotype 3 HCV, either singly or in combination
by: Gupte Gouri M, et al.
Published: (2012-03-01)

Porcine Deltacoronavirus Accessory Protein NS7a Antagonizes IFN-β Production by Competing With TRAF3 and IRF3 for Binding to IKKε
by: Puxian Fang, et al.
Published: (2020-06-01)

Characterization of a multipurpose NS3 surface patch coordinating HCV replicase assembly and virion morphogenesis.
by: Olaf Isken, et al.
Published: (2022-10-01)

NS3 Resistance-Associated Variants (RAVs) in Patients Infected with HCV Genotype 1a in Spain.
by: María Ángeles Jimenez-Sousa, et al.
Published: (2016-01-01)

Enhanced T Cell Responses Induced by a Necrotic Dendritic Cell Vaccine, Expressing HCV NS3
by: Zelalem A. Mekonnen, et al.
Published: (2020-11-01)

Direct binding of ledipasvir to HCV NS5A: mechanism of resistance to an HCV antiviral agent.
by: Hyock Joo Kwon, et al.
Published: (2015-01-01)

Construction of pIRES2 vector encoding truncated NS3 of HCV and IL-18 for DNA vaccine studies
by: M Zavvar, et al.
Published: (2015-05-01)

Cloning and expression of NS3 helicase fragment of hepatitis C virus and the study of its immunoreactivity in HCV infected patients
by: Mahrou Sadri, et al.
Published: (2015-02-01)

The Future of HCV Therapy: NS4B as an Antiviral Target
by: Hadas Dvory-Sobol, et al.
Published: (2010-11-01)

Correction: Induction of Intrahepatic HCV NS4B, NS5A and NS5B-Specific Cellular Immune Responses following Peripheral Immunization.
by: Krystle A. Lang Kuhs, et al.
Published: (2013-01-01)

Crystal structures of full length DENV4 NS2B-NS3 reveal the dynamic interaction between NS2B and NS3
by: Phoo, Wint Wint, et al.
Published: (2022)

The NS4A Cofactor Dependent Enhancement of HCV NS3 Protease Activity Correlates with a 4D Geometrical Measure of the Catalytic Triad Region.
by: Hamzah A Hamad, et al.
Published: (2016-01-01)

An IRF-3-, IRF-5-, and IRF-7-Independent Pathway of Dengue Viral Resistance Utilizes IRF-1 to Stimulate Type I and II Interferon Responses
by: Aaron F. Carlin, et al.
Published: (2017-11-01)

Deep sequencing analysis of HCV NS3 resistance-associated variants and mutation linkage in liver transplant recipients.
by: Mariana E Kirst, et al.
Published: (2013-01-01)

Investigation of NS3 Protease Resistance-Associated Variants and Phenotypes for the Prediction of Treatment Response to HCV Triple Therapy.
by: Julia Dietz, et al.
Published: (2016-01-01)

pH-dependent conformational changes in the HCV NS3 protein modulate its ATPase and helicase activities.
by: Gustavo Tavares Ventura, et al.
Published: (2014-01-01)

Response to combination therapy of HCV 3a infected Pakistani patients and the role of NS5A protein
by: Iqbal Aqib, et al.
Published: (2011-05-01)

Spinning strings in AdS3×S3 with NS–NS flux
by: Rafael Hernández, et al.
Published: (2014-11-01)

The NS5A domain II of HCV : conservation of intrinsic disorder in several genotypes
by: Hanoulle, Xavier, et al.
Published: (2012)

PLAAT1 inhibits type I interferon response via degradation of IRF3 and IRF7 in Zebrafish
by: Xin Zhao, et al.
Published: (2022-09-01)

Deconvoluting the composition of low-frequency hepatitis C viral quasispecies: comparison of genotypes and NS3 resistance-associated variants between HCV/HIV coinfected hemophiliacs and HCV monoinfected patients in Japan.
by: Masato Ogishi, et al.
Published: (2015-01-01)

Molecular characteristics, expression analysis and antiviral activity against RSIV of red sea bream IRF3 and IRF7
by: Min-Soo Joo, et al.
Published: (2022-12-01)

1<i>H</i>-Imidazole-2,5-Dicarboxamides as NS4A Peptidomimetics: Identification of a New Approach to Inhibit HCV-NS3 Protease
by: Abdelsattar M. Omar, et al.
Published: (2020-03-01)

Characterization of Naturally Occurring NS5A and NS5B Polymorphisms in Patients Infected with HCV Genotype 3a Treated with Direct-Acting Antiviral Agents
by: Barbara Bartolini, et al.
Published: (2017-08-01)

Sequencing of E2 and NS5A regions of HCV genotype 3a in Brazilian patients with chronic hepatitis
by: Fernanda de Mello Malta, et al.
Published: (2010-02-01)